Paper42318366
Retrospective analysis of HIV pre-exposure prophylaxis (PrEP) awards under Executive Order 14168 on gender ideology in the U.S. 2012-2025.
Hall E. Public Health Pract (Oxf), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Retrospective analysis of HIV pre-exposure prophylaxis (PrEP) awards under Executive Order 14168 on gender ideology in the U.S. 2012-2025. Papers, record 42318366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42318366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Retrospective analysis of HIV pre-exposure prophylaxis (PrEP) awards under Executive Order 14168 on gender ideology in the U.S. 2012-2025.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35687813 | Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review. | AIDS Patient Care STDS | 2022 | https://conductscience.org/library/papers/35687813 | PubMed |
| 2 | 31155275 | Gender inequality and restrictive gender norms: framing the challenges to health. | Lancet | 2019 | https://conductscience.org/library/papers/31155275 | PubMed |
| 3 | 35902088 | Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV. | J Law Med Ethics | 2022 | https://conductscience.org/library/papers/35902088 | PubMed |
| 4 | 24322537 | HIV epidemics among transgender women. | Curr Opin HIV AIDS | 2014 | https://conductscience.org/library/papers/24322537 | PubMed |
| 5 | 30950883 | Mental health and HIV/AIDS: the need for an integrated response. | AIDS | 2019 | https://conductscience.org/library/papers/30950883 | PubMed |
| 6 | 37698755 | Integrated Care Models: HIV and Substance Use. | Curr HIV/AIDS Rep | 2023 | https://conductscience.org/library/papers/37698755 | PubMed |
| 7 | 35876653 | Longitudinal HIV care outcomes by gender identity in the United States. | AIDS | 2022 | https://conductscience.org/library/papers/35876653 | PubMed |
| 8 | 29504062 | Sex Differences in HIV Infection. | Curr HIV/AIDS Rep | 2018 | https://conductscience.org/library/papers/29504062 | PubMed |
| 9 | 35339585 | Support for evidence-informed opioid policies and interventions: The role of racial attitudes, political affiliation, and opioid stigma. | Prev Med | 2022 | https://conductscience.org/library/papers/35339585 | PubMed |
| 10 | 33493438 | The case for prescribing PrEP in community mental health settings. | Lancet HIV | 2021 | https://conductscience.org/library/papers/33493438 | PubMed |
| 11 | 31235434 | For the HIV epidemic to end so must gender inequality. | Lancet HIV | 2019 | https://conductscience.org/library/papers/31235434 | PubMed |
| 12 | 18445809 | Dimensions of sexual orientation and HIV-related risk among adolescent females: evidence from a statewide survey. | Am J Public Health | 2008 | https://conductscience.org/library/papers/18445809 | PubMed |
| 13 | 26095483 | Opioid abuse in the United States and Department of Health and Human Services actions to address opioid-drug-related overdoses and deaths. | J Pain Palliat Care Pharmacother | 2015 | https://conductscience.org/library/papers/26095483 | PubMed |
| 14 | 36416569 | Inclusion of Transgender and Gender Diverse People in Phase III Trials: Examples from HIV Pharmacologic Prevention Studies. | Clin Pharmacol Ther | 2023 | https://conductscience.org/library/papers/36416569 | PubMed |
| 15 | 37606667 | Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. | JAMA | 2023 | https://conductscience.org/library/papers/37606667 | PubMed |
| 16 | 24328642 | Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. | Am J Public Health | 2014 | https://conductscience.org/library/papers/24328642 | PubMed |
| 17 | 36225134 | Ethical HIV research with transgender and non-binary communities in the United States. | J Int AIDS Soc | 2022 | https://conductscience.org/library/papers/36225134 | PubMed |
| 18 | 29126186 | The Importance of Human Immunodeficiency Virus Research for Transgender and Gender-Nonbinary Individuals. | Clin Infect Dis | 2018 | https://conductscience.org/library/papers/29126186 | PubMed |
| 19 | 39546769 | Mapping Implementation Strategies to Address Barriers to Pre-Exposure Prophylaxis Use Among Women Through POWER Up (Pre-Exposure Prophylaxis Optimization Among Women to Enhance Retention and Uptake): Content Analysis. | JMIR Form Res | 2024 | https://conductscience.org/library/papers/39546769 | PubMed |
| 20 | 39905253 | 'Mind-boggling': US CDC orders gender-related terms cut from scientific papers. | Nature | 2025 | https://conductscience.org/library/papers/39905253 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42318366
GET https://conductscience.org/api/papers/v1/42318366/references?page=2